Hyperbaric oxygen therapy for chronic radiotherapy-related adverse effects: A clinically focused review.

Although numerical differences were observed, these did not reach statistical significance because the trial was again markedly underpowered, with only 41% of the target sample accrued and a relevant 33% drop‐out rate (which had prompted the pooling of results in the first place).

also in 111,027 other papers